tradingkey.logo

Polyrizon Ltd

PLRZ
查看詳細走勢圖
12.845USD
+0.400+3.22%
收盤 02/06, 16:00美東報價延遲15分鐘
12.59M總市值
虧損本益比TTM

Polyrizon Ltd

12.845
+0.400+3.22%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+3.22%

5天

+11.60%

1月

-4.21%

6月

+94.62%

今年開始到現在

+51.30%

1年

-99.24%

查看詳細走勢圖

TradingKey 股票評分

由於缺少必要的數據,暫時無法對該公司進行評分

Polyrizon Ltd新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Polyrizon Ltd簡介

Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..
公司代碼PLRZ
公司Polyrizon Ltd
CEOIzraeli (Tomer)
網址https://polyrizon-biotech.com/
KeyAI